Bruno Daniel Costa Gomes

Bruno Daniel Costa Gomes is an Assistant Professor at Universidade Lusófona de Humanidades e Tecnologias, Escola de Psicologia e Ciências da Vida, and an Invited Assistant Professor at Universidade Nova de Lisboa, Faculdade de Ciências Médicas. His academic work is deeply rooted in Medical and Health Sciences, with a specialization in Genetics, Oncology, and Toxicology. He has held research positions at Instituto de Medicina Molecular (IMM) and Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), contributing to translational and public health research.

• PhD in Life Sciences (Genetics, Human Toxicology, Oncology), Universidade Nova de Lisboa (2016)
• Bachelor’s in Biology, Universidade Lusófona de Humanidades e Tecnologias (2008)
• Postgraduate: Laboratory Animal Sciences (Felasa B), Clinical Trials, Bioinformatics, Molecular Pathology

His research focuses on the role of microRNAs in cancer susceptibility and progression, DNA repair polymorphisms, and the molecular basis of drug resistance in breast and thyroid cancers. He also investigates human biomonitoring of occupational exposure to toxicants such as hexavalent chromium and PAHs, contributing to environmental and occupational health risk assessment. His work bridges molecular biology with public health applications.

The 15 most recent publications highlight a consistent trajectory in cancer genetics and toxicology. Themes include microRNA regulation, chemoresistance mechanisms, genotoxicity biomarkers, and environmental exposure assessment. The studies employ molecular techniques, bioinformatics, and epidemiological approaches, reflecting an interdisciplinary research profile focused on biomarker discovery and mechanistic insights into disease and exposure.

Bruno has supervised multiple MSc students and has collaborated with over 150 researchers. His work has been published in journals such as Genes, Frontiers in Genetics, Toxics, and Annals of Work Exposures and Health. While no specific awards are listed, his contributions to collaborative European projects like HBM4EU underscore his recognition in the field.

He is actively involved in teaching and research, with no indication of part-time or retired status. His ORCID (0000-0002-5632-1095) links to a robust publication record, and his email is gomes@outlook.com. No dedicated lab or team is mentioned, but his affiliations suggest integration into broader research networks in molecular medicine and public health.